| Stage | ECVT | % of rev | SOLS | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $250M | 100.00% | $1.1B | 100.00% | SOLS ×4.59 |
| Gross profit | $50M | 19.94% | $370M | 32.23% | SOLS +12.3pp |
| Operating income | $19M | 7.75% | $197M | 17.16% | SOLS +9.4pp |
| Pre-tax income | $15M | 5.96% | $176M | 15.33% | SOLS +9.4pp |
| Net income | $8M | 3.15% | $134M | 11.67% | SOLS +8.5pp |
| Stage | ECVT | SOLS | Gap · A − B |
|---|---|---|---|
| Revenue | $250M100.00% | $1.1B100.00% | SOLS ×4.59 |
| Gross profit | 19.94%$50M | 32.23%$370M | SOLS +12.3pp |
| Operating income | 7.75%$19M | 17.16%$197M | SOLS +9.4pp |
| Pre-tax income | 5.96%$15M | 15.33%$176M | SOLS +9.4pp |
| Net income |
| 3.15%$8M |
| 11.67%$134M |
| SOLS +8.5pp |
No shared counterparties.